SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr
6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok
- Annual General Meeting on Mar. 26th,agendas include director appointment SEOUL,South Korea,Feb. 25,2025-- KT&G Corporation ("KT&G" or the "Company") (KRX:033780) held a
XUZHOU,China,Feb. 25,2025--The 3rd XCMG & FinDreams Super Battery Day was successfully held at the XCMG International Conference Center,Xuzhou,focused on cutting-edge technologies and explored new
